Diabetes conferences rarely include shock announcements, and this year’s American Diabetes Association Annual Scientific Sessions, held in New Orleans, proved as such.
Any uncertainty was quashed well before the conference. On May 31, Dexcom refuted a rumor founded in a May...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?